Bespak Europe Ltd:企業の製品パイプライン分析2018

◆英語タイトル:Bespak Europe Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C3017
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥207,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥310,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator, easfill metered dose inhaler valves and metered dose inhaler valves and actuators. Bespak offers device design and development; device on demand, metrology, rapid prototyping, analytical services, marketing support and lifecycle, program management, and quality and regulatory management services. The company has its presence in Norfolk, Hertfordshire, Cambridge, Milton Keynes and Lancashire. Bespak is headquartered in King’s Lynn, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bespak Europe Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bespak Europe Ltd Company Overview 4
Bespak Europe Ltd Company Snapshot 4
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd – Pipeline Analysis Overview 6
Bespak Europe Ltd – Key Facts 6
Bespak Europe Ltd – Major Products and Services 7
Bespak Europe Ltd Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Overview 10
Bolus Drug Delivery Device 10
Bolus Drug Delivery Device Product Overview 10
DEV610 DPI 11
DEV610 DPI Product Overview 11
IDC300 Integrated Dose Counter 12
IDC300 Integrated Dose Counter Product Overview 12
NAS010 13
NAS010 Product Overview 13
NAS020 – Unidose Nasal Drug Delivery Device 14
NAS020 – Unidose Nasal Drug Delivery Device Product Overview 14
NAS030 Nasal Device 15
NAS030 Nasal Device Product Overview 15
OCU050 Ophthalmic Drug Delivery Device 16
OCU050 Ophthalmic Drug Delivery Device Product Overview 16
VAL020 Metered Dose Inhaler Valve 17
VAL020 Metered Dose Inhaler Valve Product Overview 17
VAL050 pMDI Valve / Actuator 18
VAL050 pMDI Valve / Actuator Product Overview 18
VAL310 Easifill Valve 19
VAL310 Easifill Valve Product Overview 19
Bespak Europe Ltd – Key Competitors 20
Bespak Europe Ltd – Key Employees 21
Bespak Europe Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Bespak Europe Ltd, Recent Developments 23
Oct 17, 2016: Bespak Launches Syrina AR 2.25 Auto-injector For Fully-automatic Delivery Of Viscous Drug Formulations 23
Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 23
Jun 16, 2016: Consort Medical Provides Update on DEV610 development programme 23
Oct 08, 2015: Consort Medical Launches New Brand Identity To The Market 24
Oct 08, 2015: Bespak Launches New Brand Identity To The Market 24
Feb 11, 2015: Bespak Launches Syrina 2.25 At PDA Europe 25
Nov 28, 2013: Major long-term commercial supply contract award – dry powder inhaler 25
Sep 02, 2013: Consort Medical Issues its Interim Management Statement 26
Jul 23, 2013: Bespak Receives Contract To Develop Nasal Drug Delivery Device 26
Jul 22, 2013: Bespak development contract award 26
Appendix 27
Methodology 27
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Bespak Europe Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Indication 5
Bespak Europe Ltd, Key Facts 6
Bespak Europe Ltd, Major Products and Services 7
Bespak Europe Ltd Number of Pipeline Products by Development Stage 8
Bespak Europe Ltd Pipeline Products Summary by Development Stage 9
Bolus Drug Delivery Device - Product Status 10
Bolus Drug Delivery Device - Product Description 10
DEV610 DPI - Product Status 11
DEV610 DPI - Product Description 11
IDC300 Integrated Dose Counter - Product Status 12
IDC300 Integrated Dose Counter - Product Description 12
NAS010 - Product Status 13
NAS010 - Product Description 13
NAS020 - Unidose Nasal Drug Delivery Device - Product Status 14
NAS020 - Unidose Nasal Drug Delivery Device - Product Description 14
NAS030 Nasal Device - Product Status 15
NAS030 Nasal Device - Product Description 15
OCU050 Ophthalmic Drug Delivery Device - Product Status 16
OCU050 Ophthalmic Drug Delivery Device - Product Description 16
VAL020 Metered Dose Inhaler Valve - Product Status 17
VAL020 Metered Dose Inhaler Valve - Product Description 17
VAL050 pMDI Valve / Actuator - Product Status 18
VAL050 pMDI Valve / Actuator - Product Description 18
VAL310 Easifill Valve - Product Status 19
VAL310 Easifill Valve - Product Description 19
Bespak Europe Ltd, Key Employees 21
Bespak Europe Ltd, Other Locations 22
Glossary 29

List of Figures
Bespak Europe Ltd Pipeline Products by Equipment Type 5
Bespak Europe Ltd Pipeline Products by Development Stage 8

★海外企業調査レポート[Bespak Europe Ltd:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CytoSorbents Corp (CTSO):企業の財務・戦略的SWOT分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Acciona SA (ANA):企業の財務・戦略的SWOT分析
    Acciona SA (ANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Park Group plc:企業の戦略・SWOT・財務情報
    Park Group plc - Strategy, SWOT and Corporate Finance Report Summary Park Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hanmi Pharmaceuticals Co Ltd (128940):製薬・医療:M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Texas Instruments Incorporated (TXN):医療機器:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • CJ O Shopping Co.,Ltd (035760):企業の財務・戦略的SWOT分析
    CJ O Shopping Co.,Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Saudi Cable Company (2110):企業の財務・戦略的SWOT分析
    Saudi Cable Company (2110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Edison S.p.A.:企業の戦略・SWOT・財務分析
    Edison S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Edison S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Falck Renewables S.p.A. (FKR):電力:M&Aディール及び事業提携情報
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A that develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, bioma …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, creative, photography and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • Empresaria Group plc (EMR):企業の財務・戦略的SWOT分析
    Empresaria Group plc (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sistema JSFC:企業の戦略・SWOT・財務情報
    Sistema JSFC - Strategy, SWOT and Corporate Finance Report Summary Sistema JSFC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Amey Plc:企業の戦略的SWOT分析
    Amey Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Punjab National Bank:企業の戦略・SWOT・財務分析
    Punjab National Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cosmo Pharmaceuticals NV (COPN)-医療機器分野:企業M&A・提携分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatm …
  • International Paper Co:戦略・SWOT・企業財務分析
    International Paper Co - Strategy, SWOT and Corporate Finance Report Summary International Paper Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Armstrong World Industries Inc (AWI):企業の財務・戦略的SWOT分析
    Armstrong World Industries Inc (AWI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆